Acadian Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,819
Closed -$160K 2157
2024
Q2
$160K Buy
+3,819
New +$210K ﹤0.01% 1466
2021
Q2
Sell
-1,121
Closed -$148K 2056
2021
Q1
$148K Sell
1,121
-2,968
-73% -$406K ﹤0.01% 1578
2020
Q4
$542K Buy
+4,089
New +$494K ﹤0.01% 1209
2018
Q1
Sell
-153
Closed -$8K 1716
2017
Q4
$8K Hold
153
﹤0.01% 1438
2017
Q3
$7K Buy
+153
New +$6.16K ﹤0.01% 1299

Other funds holding EXAS

Acadian Asset Management's EXAS Position: Q3 2024 in Review

Acadian Asset Management sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 3,819 shares — an estimated $160K sold.

Acadian Asset Management first reported a position in EXAS in Q3 2017 and held it in 5 quarters. The position peaked at $542K in Q4 2020. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Acadian Asset Management reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Acadian Asset Management sold 3,819 Exact Sciences shares in Q3 2024, an estimated $160K.
  • Acadian Asset Management first reported a position in Exact Sciences in Q3 2017 and held it in 5 quarters.
  • Acadian Asset Management's Exact Sciences position peaked at $542K in Q4 2020.
  • 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Acadian Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.